PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced that Peter R. Young, Ph.D. has joined the company in the newly created position of vice president, Research. Dr. Young joins the company with over 20 years of experience in pharmaceutical and biotechnology drug research in oncology, cardiovascular, metabolic, inflammatory and anti-viral disease therapeutic areas.
